Literature DB >> 7429549

The relationship between the binding ability and the rate of activation of the complement component C1.

E J Folkerd, B Gardner, N C Hughes-Jones.   

Abstract

The strength of the bond between C1 and C1 binders (as measured by C1q binding) has been correlated with the ability of the binders to activate C1. The rate of activation of C1 has been studied by following the extent of hydrolysis of the C1r and C1s subcomponents, using a purified preparation of C1 labelled with 125I. The rate of activation of C1 was not correlated with the binding strength between C1q and the C1 binders. Immune complexes were found to activate C1 rapidly, whereas glutaraldehyde-aggregated IgG failed to activate faster than the spontaneous activation seen on incubation of C1 alone; the strength of the bond between C1q and the binders was similar in the two cases. It is suggested that an interaction other than the binding between C1q and C1 binders is necessary for activation of C1. C1 bound to immune complexes was not activated in the presence of C1 inhibitor, indicating that the inhibitor can prevent the hydrolysis of C1r under the test conditions.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7429549      PMCID: PMC1458229     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  20 in total

1.  Activation of C1r by proteolytic cleavage.

Authors:  R J Ziccardi; N R Cooper
Journal:  J Immunol       Date:  1976-02       Impact factor: 5.422

2.  The unactivated form of the first component of human complement, C1.

Authors:  I Gigli; R R Porter; R B Sim
Journal:  Biochem J       Date:  1976-09-01       Impact factor: 3.857

3.  Studies on the complement-binding site of rabbit immunoglobulin G-11. The reaction of rabbit IgG and its fragments with Clq.

Authors:  R Allan; H Isliker
Journal:  Immunochemistry       Date:  1974-05

4.  Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane.

Authors:  G Fairbanks; T L Steck; D F Wallach
Journal:  Biochemistry       Date:  1971-06-22       Impact factor: 3.162

5.  Effect of chemical and enzymatic radioiodination on in vitro human Clq activities.

Authors:  C Heusser; M Boesman; J H Nordin; H Isliker
Journal:  J Immunol       Date:  1973-03       Impact factor: 5.422

6.  The mechanism of activation of the first component of complement by a univalent hapten-IgG antibody complex.

Authors:  J W Goers; R J Ziccardi; V N Schumaker; M M Glovsky
Journal:  J Immunol       Date:  1977-06       Impact factor: 5.422

7.  Functional affinity constants of the reaction between 125I-labelled C1q and C1q binders and their use in the measurement of plasma C1q concentrations.

Authors:  N C Hughes-Jones
Journal:  Immunology       Date:  1977-02       Impact factor: 7.397

8.  Isolation and characterization of the proenzyme form of the C1s subunit of the first complement component.

Authors:  G Valet; N R Cooper
Journal:  J Immunol       Date:  1974-01       Impact factor: 5.422

9.  The structure and enzymic activities of the C1r and C1s subcomponents of C1, the first component of human serum complement.

Authors:  R B Sim; R R Porter; K B Reid; I Gigli
Journal:  Biochem J       Date:  1977-05-01       Impact factor: 3.857

10.  The enzymatic nature of C'1r. Conversion of C'1s to C'1 esterase and digestion of amino acid esters by C'1r.

Authors:  G B Naff; O S Ratnoff
Journal:  J Exp Med       Date:  1968-10-01       Impact factor: 14.307

View more
  7 in total

Review 1.  Biological activities of C1 inhibitor.

Authors:  Alvin E Davis; Pedro Mejia; Fengxin Lu
Journal:  Mol Immunol       Date:  2008-07-31       Impact factor: 4.407

2.  Structural features of the first component of human complement, C1, as revealed by surface iodination.

Authors:  C L Villiers; S Chesne; M B Lacroix; G J Arlaud; M G Colomb
Journal:  Biochem J       Date:  1982-04-01       Impact factor: 3.857

3.  Initiation of complement activation.

Authors:  P J Lachmann; N C Hughes-Jones
Journal:  Springer Semin Immunopathol       Date:  1984

4.  Influence of aggregate size on the binding and activation of the first component of human complement by soluble IgG aggregates.

Authors:  G Doekes; L A Vanes; M R Daha
Journal:  Immunology       Date:  1982-04       Impact factor: 7.397

5.  Formation of complement subcomponent C1q-immunoglobulin G complex. Thermodynamic and chemical-modification studies.

Authors:  E J Emanuel; A D Brampton; D R Burton; R A Dwek
Journal:  Biochem J       Date:  1982-08-01       Impact factor: 3.857

Review 6.  The first component of human complement (C1): activation and control.

Authors:  R J Ziccardi
Journal:  Springer Semin Immunopathol       Date:  1983

7.  Human monoclonal IgG isotypes differ in complement activating function at the level of C4 as well as C1q.

Authors:  C I Bindon; G Hale; M Brüggemann; H Waldmann
Journal:  J Exp Med       Date:  1988-07-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.